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The role of Ca2+/calmodulin-dependent processes in 
the activation of the Na+/H+ antiport of primary cul- 
tures of rat aortic smooth muscle was studied using 
”Na+ uptake and measurement of intracellular pH 
(pH:) with the fluorescent pH dye  2’,7’-bis-(2-carbox- 
yethyl)-5(and  6)-carboxyfluorescein. Antiport activa- 
tion following exposure to serum  and  by the induction 
of an intracellular acidosis could  be markedly atten- 
uated by calmodulin antagonists. Ionomycin also tran- 
siently  elevated pHi and 5-(N-ethyl-N-isopropyl) 
amiloride-sensitive “Na+ influx, effects consistent 
with activation of the antiport; these effects  were abol- 
ished in cells exposed to calmodulin antagonists or 
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid. Ac- 
tivation of the antiport following intracellular acidosis 
was markedly affec:ed by cellular ATP depletion. A 
comparison  of the abilities of control and 2-deoxy-~- 
glucose-treated cells to increase 5-(N-ethyl-N-isopro- 
py1)amiloride-sensitive 22Na+ influx  in response to 
graded acidifications indicated that attenuation of Na+/ 
/H+ antiport activity  was due to both a shift of its pHi 
dependence and to a reduction in maximal activity. 
The results suggest that the Na+/H+ antiport of rat 
aortic smooth muscle is dependent on Ca2+/calmodulin- 
dependent processes, presumably phosphorylation, 
which influences its activity by modulating (i) an in- 
tracellular proton dependent regulatory mechanism 
(allosteric site) and (ii) the maximum activity of the 
antiport. 
An amiloride-sensitive Na+/H+  antiport has been detected 
in the plasma membranes of most mammalian cells (1, 2). 
Under normal circumstances this  antiport catalyzes the elec- 
troneutral exchange of intracellular  protons for extracellular 
sodium ions. In vascular smooth muscle we have shown that 
Na+/H+  antiport activity represents  a major mechanism for 
Na’ influx (3). It is also the prime mechanism responsible for 
intracellular pH  control  (4). The  antiport can be activated by 
intracellular acidosis and agents such as angiotensin I1 (5), 
growth factors (6), and phorbol esters (5). However, despite 
the ability of phorbol esters to activate the  antiport in aortic 
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smooth muscle, its activation by angiotensin I1 (5) and serum 
(6) occurs by mechanisms independent of protein kinase C. 
Agents such as angiotensin 11, serum, and platelet-derived 
growth factor also induce an increase in  the cytoplasmic free 
Ca2+ concentration ([Ca2+],).‘ This change in [Ca2+Ii usually 
precedes activation of the  antiport (7, 8), suggesting a causal 
relationship. Moreover, the involvement of [Ca2+Ii in the 
activation of the Na+/H+ antiport of some cells is further 
supported by the inhibitory effects of calmodulin antagonists 
on activation of the  antiport  as well as  the finding that  the 
divalent cation ionophore A23187 activates the  antiport  in 
AIO smooth muscle cells (9) and  human foreskin fibroblasts 
(10-12). However, this effect does not apply to all cells, 
because in fibroblasts (13) and in mouse neuroblastoma cells 
(14) A23187 does not increase antiport activity. 
Thus, although intracellular acidosis and a number of 
agents  activate the Na+/H’ antiport of vascular smooth mus- 
cle, the molecular mechanisms involved in  this activation are 
unknown. In  the present study we have carried out  a detailed 
investigation of the effects of calmodulin antagonists, changes 
in [Ca2+Ii by ionomycin, and cellular ATP depletion on Na+/ 
H+ antiport activation following exposure of the cells to serum 
and  the induction of intracellular acidosis. Evidence is pre- 
sented that,  in aortic smooth muscle, activation of the  antiport 
is dependent upon calmodulin, [Ca2+]i, and cellular ATP. The 
overall results suggest that these  agents influence, probably 
via phosphorylation, the activity of the  antiport  at wo regu- 
latory sites. One involves the regulation of intracellular  proton 
affinity and  the  other influences its maximal activity. 
EXPERIMENTAL PROCEDURES 
Culture of Vascular Smooth Musck-Aortic smooth muscle cells 
from adult Sprague-Dawley rats (body weight 200-300 g)  were isolated 
by collagenase and elastase digestion and grown in  culture as previ- 
ously described (3). Briefly, the cells were initially seeded at 1 X lo6 
cells/cmz onto 30-mm diameter plastic culture dishes (Sterilin Ltd., 
Feltbam, Great  Britain) and maintained  in culture for 3-4 days in 
Medium 199 containing 5% fetal calf serum. For experiments involv- 
ing the determination of intracellular pH (pH;), the cells were cultured 
on glass coverslips which are placed into  the culture dishes during 
the initial seeding (4). Vascular smooth muscle cells cultured in this 
manner stain positively with fluorescein isothiocyanate-labeled anti- 
bodies specific for smooth muscle myosin (3) and contain a-actin  as 
the major actin isoform (15). Unless stated otherwise, all cells used 
in the experiments were “serum-deprived by replacing the growth 
medium with Medium 199 containing 0.46% w/v bovine serum albu- 
min 24 h prior to experimentation. 
The abbreviations used are: [Ca2+];, cytoplasmic free Ca2+ concen- 
tration; pHi, intracellular pH, BCECF, 2’,7’-bis-(2-carboxyethyl)- 
5(and 6)-carboxyfluorescein; HEPES, 4-(2-hydroxyethyl)-l-pipera- 
zineetbanesulfonic acid; EGTA, [ethylenebis(oxyethylenenitrilo)]tet- 
raacetic acid; EIPA, 5-(N-ethyl-N-isopropyl)amiloride. 
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Salt Solutions-The standard salt solution (solution A) used in the 
experiments consisted of 135 mM NaCl, 5 mM KCl, 1.8 mM CaC12, 
0.8 mM MgS04, 5.5 mM glucose in 10 mM HEPES-Tris adjusted to 
pH 7.4 at 37  "C. For experiments involving the uptake of "Na+ into 
cells, solution B was used. Its composition was as for solution A 
except that it contained 15 mM NaCl and 120 mM N-methyl-D- 
glucamine chloride instead of the 135 mM NaCl. Other chemicals 
were added as required to these solutions. 
22Na+ Uptake Measurements--22Na+ influx in the cultured cells 
was measured as previously described (3). Briefly, in  the experiments 
involving "Na+ uptake determinations, the cells were rinsed and 
equilibrated at  37 "C for 15 min in solution B (containing 15 mM 
Na+). After this interval the solution was aspirated and replaced by 
a similar solution containing 2 mM ouabain and  the compounds of 
interest. After 3 min, "Na+ (carrier-free, lo6 cpm) was added to  the 
incubations and isotope uptake measured at 37 "C over the ensuing 
3-min period. "Na+ uptake was terminated by rapidly removing the 
incubation mix and washing (five times) the cells with ice-cold 0.1 M 
MgClz. The cells were harvested by scraping into 0.1 M nitric acid 
and centrifuged. Radioactivity due to liberated "Na+ was determined 
in the  supernatant fraction using a liquid scintillation  counter, and 
the cell pellets were assessed for protein using the method of Lowry 
et al. (16). Na+/H+  antiport activity was taken  as  the difference in 
"Na+ uptake measured in the absence and presence of EIPA (400 
p ~ )  following inhibition of the Na+/K+-pump with 2 mM ouabain. 
This concentration of EIPA induces maximal inhibition of Na+/H+ 
exchange in vascular smooth muscle (3). 
Measurement of pHi-The fluorescent pH indicator BCECF was 
used to monitor changes in cytosolic pH. Briefly, the method involved 
washing (three times) the smooth muscle attached to  the coverslips 
with solution A followed by incubation at 37  "C in 1 ml of solution A 
containing 0.2 nmol of BCECF-AM. At the end of the incubation the 
coverslips were washed (three times) with solution A at  37 "C to 
remove any extracellular indicator. The coverslips were then loaded 
into  a vertical coverslip holding device (17) which could be inserted 
into  a  standard (1 cm X 1 cm) fluorescence cuvette thermostated at 
37 "C and perfused with a variety of media (see individual experi- 
ments). Fluorescence determinations were carried out using a  Perkin 
Elmer LS-5 Luminescence spectrometer whose excitation wavelength 
was varied between 495 and 440 nm, but the emission wavelength 
remained at 530 nm. Under these conditions, the leakage of BCECF 
from cells on coverslips over a  15-min period is negligible (4). Inter- 
ference due to autofluorescence and light scatter of unloaded cells 
represented less than 2% of the  total 495  nm signal of BCECF-loaded 
cells. The ratio of the fluorescence signal from the two excitation 
wavelengths (495 nm and 440 nm) from BCECF-loaded cells was 
calibrated to pHi using high (140 mM) potassium buffers of various 
pH levels containing  4 p M  nigericin (4, 15). 
Materials-N-(4-Aminobutyl)-2-naphthalenesulfonamide HC1 
(W-12) was purchased from Seikagaku Kogyo, Tokyo, Japan.  N-(4- 
Aminobutyl)-5-chloro-2-naphthalenesulfonamide HCl (W-13), N-(6- 
aminohexyl)-5-chloro-l-naphthalenesulfonamide HCl (W-7), N -  
methyl-D-glucamine, EGTA, 2-deoxy-~-glucose, 3-O-methylglucose 
haloperidol, and rotenone were purchased from Sigma. Ionomycin 
and  HEPES were purchased from Behring Diagnostics. Trifluoroper- 
azine HCl was a gift from Smith, Kline, and French Labs (Australia) 
Ltd., Sydney, Australia. Diazepam was purchased from David Bull 
Laboratories, Melbourne, Australia. BCECF and BCECF-AM were 
purchased from Molecular Probes, Eugene, OR. 5-(N-Ethyl-N-iso- 
propyl)-amiloride (EIPA) was synthesized as previously described 
(18). All other chemicals, biochemicals, and culture media were ob- 
tained from standard chemical suppliers. 
RESULTS 
Effect of Calmodulin Antagonists on Na+/H+ Antiport Activ- 
ity-The  role of calmodulin-dependent processes in  the acti- 
vation of the  Na+/H+  antiport was initially investigated by 
assessing the effects of two  closely related calmodulin antag- 
onists, compounds W-12 and W-13, on EIPA-sensitive "Na+ 
influx rate, measured in  the presence of 10% serum (Fig. 1). 
Preincubation of 4 h serum-deprived cells for 30 min with W- 
13 attenuated  EIPA-sensitive "Na+ influx in a  concentration- 
dependent manner (Fig. 1). This  inhibition of EIPA-sensitive 
"Na+ influx by the highest concentration of W-13 (400 FM), 
approximately 95%, was due not only to inhibition of the 
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FIG. 1. Inhibition by calmodulin antagonists of EIPA-sen- 
sitive "Na+ influx in vascular smooth muscle exposed to 10% 
serum. Cells deprived of serum for 4  h were rinsed free of culture 
medium and incubated at 37 "C in solution B containing various 
concentrations of the calmodulin antagonists W-12 or W-13. After 
30 min, the solution was aspirated and replaced by a similar solution 
containing 10% fetal calf serum (final Na+, 15 mM), 2 mM ouabain, 
and  the calmodulin antagonists W-12 (0) and W-13 (0) with and 
without EIPA. After 3 min incubation at  37 "C, "Na+ (lo6 cpm) was 
added and  its uptake  into cells measured over the next 3 min. Data 
are the means of three similar experiments. 
serum-stimulated component of the influx (which under these 
conditions accounts for approximately 70% of the  total  EIPA- 
sensitive "Na+ influx), but also to near-complete inhibition 
of the basal EIPA-sensitive "Na+ influx. The ICs0 for this 
inhibition by W-13 averaged 150 pM. In  contrast  to  the  potent 
effects of W-13 on EIPA-sensitive "Na+ influx, pre-incuba- 
tion of the cells with the structurally related analogue W-12 
(up  to 400  FM), a compound approximately 5 times less potent 
than W-13 on calmodulin-dependent processes (19, 20), re- 
duced EIPA-sensitive "Na+ uptake by only 33% at  the highest 
concentration (Fig. 1). 
Because antiport activity in smooth muscle appeared de- 
pendent on calmodulin-dependent processes, we next exam- 
ined whether the activation of the  Na+/H+  antiport by intra- 
cellular protons was also influenced by calmodulin-dependent 
processes. The ability of the cells to recover  from an acid load 
was examined after preexposing the cells for 20 min to two 
calmodulin antagonists W-7 (200 pM) and trifluoroperazine 
(50 PM) (21, 22). At these  concentrations, W-7 and trifluoro- 
perazine inhibit myosin light chain phosphorylation in vas- 
cular smooth muscle  by approximately 70-80% (23). In these 
experiments the NH4C1 withdrawal technique was used to 
acidify the cytoplasm. This procedure involves loading the 
cells with ammonium ions by a 4-min incubation in the 
presence of 15 mM NH4Cl, either  in the absence or presence 
of the calmodulin antagonists. Subsequent removal of NH&l 
results in a large decrease in pH; as free ammonia rapidly 
leaves the cytoplasm (see Fig. 6 for complete time course of 
pH changes). The subsequent recovery of pH; is dependent 
upon activation of the  Na+/H+  antiport (4).  In control cells 
recovery of pH; was rapid and complete within 4 min of 
introducing the acid load (Fig. 2). However, in the cells 
preincubated and  then continuously exposed to either W-7 or 
trifluoroperazine, recovery of pH; was markedly attenuated 
(Fig. 2). Neither calmodulin antagonist  had  any appreciable 
inhibitory effect on the recovery of pHi when introduced at 
the time of NH4C1 withdrawal (results  not shown). 
Intracellular Calcium and Activation of the Na+/H+ Anti- 
port-Because Ca'+/calmodulin-dependent processes ap- 
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FIG. 2. Effect of calmodulin antagonists on the Na+/H+ an- 
tiport-dependent recovery from acidosis induced by the  with- 
drawal of an NH&l preload. Cells cultured on glass coverslips 
were  loaded with the fluorescent intracellular pH indicator BCECF 
during a 30-min incubation at 37 "C with BCECF-AM dissolved in 
solution A. The calmodulin antagonists (W-7,200 pM, trifluoperazine 
(TFP), 50 p ~ )  were present during the final 15 min of the loading 
period and throughout the subsequent procedures. Intracellular aci- 
dosis  was induced by exposing the cells at 37 "C to 15 mM NH4C1 in 
solution A for 4 min prior to  its rapid withdrawal (arrow). Trace  is  a 
composite of three experiments on the same cell culture. Data are 
typical of four similar experiments with each inhibitor. 
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FIG. 3. Effect of ionomycin on pH, in aortic smooth muscle. 
Cells cultured on glass coverslips were loaded with the fluorescent 
pH indicator BCECF as indicated under "Experimental Procedures." 
Traces depict fluorescence measurements from three successive 
coverslips from the same primary culture. Top tracing depicts the 
initial alkalinization which occurs upon exposing the cells to 1 p M  
ionomycin. Middle tracing demonstrates the complete attenuation of 
the alkalinization by removal by extracellular calcium. Bottom  tracing 
demonstrates the  attenuation of the alkalinization by the  Na+/H+ 
antiport  inhibitor EIPA. Results are typical of four similar experi- 
ments. 
peared to be  involved in activating the  Na+/H+ antiport, we 
next examined the effect of increasing intracellular calcium 
on antiport activity. When cells equilibrated in solution A 
were exposed to 1 PM calcium ionophore ionomycin, the 
intracellular pH of the cells gradually rose  (Fig. 3). Approxi- 
mately 2.5-3 min  after exposure to ionomycin the elevation 
in  pH averaged 0.15 pH  units  and  thereafter declined to acidic 
levels (not shown). This  initial alkalinization could be pre- 
vented by removal of extracellular calcium and was not de- 
pendent on any  electroneutral exchange of Ca2+ for intracel- 
lular protons, because it could  be attenuated by  100 PM EIPA 
(Fig. 3). Confirmation of the ability of ionomycin to activate 
the  antiport  in aortic smooth muscle  by a calcium-dependent 
mechanism was made by assessing the effects of ionomycin 
on "Na+ entry.  In cells equilibrated in solution B, ionomycin 
initiated  a  concentration-dependent increase in EIPA-sensi- 
tive "Na+ influx (Fig. 4). The ionomycin-induced elevation 
in EIPA-sensitive "Na+ influx appeared also dependent upon 
extracellular calcium and calmodulin. EIPA-sensitive "Na+ 
influx measured in the presence of 1 PM ionomycin averaged 
25.0 f 4.3 nmol of 22Na+/min/mg of protein  and was reduced 
to 7.8 & 4.3 nmol of "Na+/min/mg of protein when EGTA (4 
mM) was present to reduce extracellular calcium to below  200 
nM. Furthermore,  a 30-min exposure to  the calmodulin antag- 
onist W-13 reduced ionomycin-stimulated EIPA-sensitive 
"Na+ influx to 4.4 f 1.8 nmol of "Na+/min/mg of protein. 
This apparent dependence of antiport activity on calmodulin 
was further evaluated by examining the effects, in  a concen- 
tration-dependent  manner, of two structurally  unrelated cal- 
modulin antagonists, haloperidol and diazepam (22). Prein- 
cubation of cells for 20 min with haloperidol and diazepam 
caused a concentration-dependent inhibition of EIPA-sensi- 
tive "Na+ influx measured in  the presence of 1 p M  ionomycin 
(Fig. 5).  The IC60 values for haloperidol and diazepam aver- 
aged  55 and 115 p ~ ,  respectively, which are  in good agreement 
with the ICso values of 60 and 140 p~ reported for the 
inhibition of the calmodulin-dependent activation of rat  brain 
phosphodiesterase (22). 
ATP and Activation of the Na+/H+ Antiport-Phosphory- 
lation of the Na+/H+  antiport  has been suggested as  a  poten- 
tial mechanism by which agents such as phorbol esters  and  a 
variety of growth factors elevate pHi (24, 25). Because in 
aortic smooth muscle activation of the  antiport by a variety 
of experimental manipulations involves Ca'+/calmodulin-de- 
pendent processes, it was of interest to investigate the effects 
of graded reductions in cellular ATP on antiport  activation. 
Reductions in cellular ATP were produced by incubating cells 
for a  total of 30-40 min in solution A (containing 5.5 mM 
glucose) or solution A in which the glucose had been replaced 
with an equimolar amount of either of the nonmetabolizable 
sugars 3-0-methylglucose or 2-deoxy-D-glucose. The latter 
sugar also consumes ATP during its initial phosphorylation 
by hexokinase, leading to rapid ATP depletion (26). Intracel- 
lular pH of cells incubated in solution A containing glucose, 
3-O-methylglucose, and 2-deoxy-~-glucose averaged 7.06 k 
C 8 7 6 
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FIG. 4. Concentration dependence of Na+/H+ antiport acti- 
vation by ionomycin. Cells were rinsed and  then equilibrated in 
solution B for 15 min. The solution was then aspirated and replaced 
by a similar solution containing "Na+ (lo6 cpm) and ionomycin in 
the absence and presence of EIPA. "Na+ uptake was measured over 
3 min, the period of time normally associated with cytosolic alkalin- 
ization by ionomycin (Fig. 3). Results are the means k S.E. of four 
experiments. 
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FIG. 5. Inhibition by calmodulin antagonists of EIPA-sen- 
sitive "Na+ influx in ionomycin-treated vascular smooth mus- 
cle. Cells were incubated at 37 "C in solution B  containing various 
concentrations of the calmodulin antagonists haloperidol or diaze- 
pam. After 20 min the solution was aspirated and replaced by a 
similar solution containing 1 p M  ionomycin (final Na+, 15 mM), 2 
mM ouabain and haloperidol (0) and diazepam (0) with and without 
EIPA. After 3 min incubation at 37 "C, "Na+ (lo6 cpm) was added 
and  its uptake  into cells measured over the next  3 min. Data  are the 
means of three similar experiments. 
0.16,  6.97 f 0.21, and 6.71 k 0.10, respectively. The ability of 
the  Na+/H+  antiport in cells exposed to 3-0-methylglucose or 
2-deoxy-~-glucose  to be activated by an acid load was atten- 
uated (Fig. 6). When the cells were preexposed to 15 mM 
NH4C1 for 3 min to induce an acid load, the subsequent 
acidosis in all three groups of cells was similar, with pH, 
averaging 6.58 f 0.18. The initial  rates of recovery in the 3- 
0-methylglucose- and 2-deoxy-~-glucose-exposed cells were 
reduced by 46.1 k 8.7 and 95 f 5%, respectively, compared 
with those incubated in solution A (Fig. 6). 
The effects of ATP depletion on the elevation in EIPA- 
sensitive "Na+ uptake induced by exposing the cells to 1 p~ 
ionomycin were also investigated. In  these experiments ATP 
depletion was induced by exposing the cells for 15 min to 
solution A in which an equimolar amount of 2-deoxy-~- 
glucose was substituted for the glucose or by exposing the 
cells to solution A containing 25 p~ rotenone. This latter 
procedure has been shown to reduce ATP levels during  this 
period by values in excess of 80% (27). Under these conditions, 
EIPA-sensitive "Na+ uptake, measured in solution B  contain- 
ing 1 pM ionomycin, was reduced from 29.8 f 1.5 nmol of 
"Na+/min/mg of protein to 3.1 k 1.3 and 7.5 f 2.9 nmol of 
"Na+/min/mg of protein  in cells incubated with 2-deoxy-~- 
glucose and rotenone, respectively. 
Mechanism of Modulation of Na+/H+ Antiport  Actiuity by 
2-Deoxy-~-glucose-Previous studies  in vascular smooth mus- 
cle indicated that intracellular protons play an important 
regulatory role in activating the Na+/H+ antiport (4). Our 
finding that  the metabolic inhibitor 2-deoxy-~-g~ucose vir- 
tually abolishes the ability of the Na+/H+ antiport to be 
activated by high intracellular  concentrations of protons (pHi - 6.6) (Fig. 6) led us to examine its effects on intracellular 
proton sensitivity and the maximal activity of the antiport. 
In these  experiments we compared the effects of preincubating 
cells in solution A or solution A containing 5.5 mM 2-deoxy- 
D-glUCOSe (substituted for glucose) on their ability to activate 
the  Na+/H+  antiport in response to graded reductions in pHi. 
Reductions in pH, were induced by preincubating the cells 
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FIG. 6. Effect of cellular ATP depletion on Na+/H+ antiport- 
mediated recovery from intracellular acidosis induced by 
NH&l preloads. Cells were  loaded with the pH fluorescent indicator 
BCECF as described under "Experimental Procedures" in solution A 
(top panel), solution A  in which  glucose had been replaced by 5.5 mM 
3-0-methylglucose (middle panel), and solution A  containing 5.5 mM 
2-deoxy-~-glucose  (substituted for the glucose). Tracings depict the 
abilities of these cells to recover from intracellular acidosis induced 
by a 15 mM NH&l preload when the cells are continuously main- 
tained  in the above-mentioned solutions. Arrows represent the times 
at which NH&l was added to  and removed from the cuvette of the 
fluorimeter. Results are typical of three or four similar experiments 
with each sugar. 
with increasing concentrations of NH4C1 (up  to 40 mM) for 
15 min prior to  its rapid removal. EIPA-sensitive "Na+ uptake 
was measured in solution B containing 2-deoxy-D-glucose 
(substituted for glucose) over a 2.5-min period immediately 
following withdrawal of NH4Cl. In agreement with previous 
reports (24, 26), EIPA-sensitive "Na+ uptake increased with 
increasing acid loads induced by  NH4C1 pre-exposure (Fig. 7). 
In control cells, half-maximal effects on EIPA-sensitive "Na+ 
uptake occurred at approximately 12 mM NH4C1.  By contrast, 
in the 2-deoxy-~-glucose-treated cells, half maximal effect on 
"Na+ uptake occurred at approximately 25 mM NH4C1, indi- 
cating  a reduction in the sensitivity of the  antiport  to increas- 
ing concentrations of intracellular protons. This effect on 
intracellular  proton sensitivity was accompanied by a marked 
reduction in the activity of the antiport. Under conditions 
which caused maximal stimulation of the  antiport (30 and 40 
mM NH4Cl), the activity of the  antiport in the  2-deoxy-~- 
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FIG. 7. Effect of preloading  aortic smooth muscle with in- 
creasing concentrations of NHICl on EIPA-sensitive "Na+ 
uptake  in  control  and 2-deoxy-~-glucose-exposed cells. Cells 
were  preincubated at 37 "C for 15 min with increasing concentrations 
(0-40 mM) of NHrCl in solution B (0) or solution B in which the 
glucose had been replaced with 5.5 mM 2-deoxy-D-glucose (0). Upon 
rapidly rinsing the cells with identical solutions free of NHICI,  "Na+ 
(lo6 cpm) was  rapidly  added and its uptake determined in  the presence 
and absence of EIPA over  a 2.5-min interval. The data are typical of 
three similar experiments. 
glucose-incubated cells was reduced by approximately 80% 
compared to control cells (Fig. 7). 
DISCUSSION 
Our results indicate that regulation of Na+/H+ antiport 
activity in vascular smooth muscle is dependent upon proc- 
esses, presumably phosphorylation, involving calcium, cal- 
modulin, and ATP, Phosphorylation processes dependent on 
protein kinase C have been suggested to be the mechanism 
by which serum and growth factors such as, for example, 
platelet-derived growth factor activate the  antiport in fibro- 
blasts (28), and lymphocytes (25). However, in other cells, 
mechanisms independent of protein kinase C activation have 
also been reported to increase Na+/H+  antiport activity. Thus, 
although phorbol ester-mediated activation of protein kinase 
C increases Na+/H+ antiport activity in lymphocytes, its 
activation by osmotic shrinking occurs by mechanisms inde- 
pendent of protein kinase C (29). In human fibroblasts (10- 
12) and in Alo smooth muscle cell line (9), activation of the 
Na+/H+  antiport by serum and platelet-derived growth factor 
appears dependent on Ca2+/calmodulin-dependent processes. 
Our results on the ability of calmodulin antagonists to inhibit 
Na+/H+ antiport activity in cultured aortic smooth muscle 
exposed to serum and ionomycin are also consistent with a 
calmodulin-dependent process being involved in its activa- 
tion. The naphthalenesulfonamide calmodulin antagonist W- 
12 was found to be at least  3 times less potent  than  its 5-  
chloro analogue W-13 (20).  Furthermore, indirect assessment 
of the ability of W-13 to inhibit smooth muscle calmodulin- 
dependent kinases, based on the equal activity of W-7 and 
W-13 to inhibit myosin light chain kinase activity (19, 20) 
and  the reported potency of W-7 to inhibit phosphorylation 
in smooth muscle (23), indicates that  the ICbo value of 150 
p~ for the inhibition of Na+/H+  antiport activity by W-13 is 
consistent with inhibition of calmodulin-dependent phos- 
phorylation processes in smooth muscle. Similarly, the inhib- 
itory potencies of two other  structurally  unrelated compounds, 
haloperidol and diazepam, are also consistent with activation 
of Na+/H+  antiport activity in vascular smooth muscle being 
mediated by calmodulin-dependent processes (see "Results"). 
Exposure of aortic smooth muscle to angiotensin I1 also 
increases Na+/H+  antiport activity by mechanisms independ- 
ent of protein kinase C ( 5 ) .  Since angiotensin I1 is known to 
activate Ca"/calmodulin-dependent processes in vascular 
smooth muscle (30), it is also probable that  the mechanism 
by which angiotensin I1 activates the  antiport also involves 
Ca2+/calmodulin. Our observations on the ability of a variety 
of calmodulin antagonists to attenuate activation of the Na+/ 
H+  antiport by intracellular acidosis and by increased intra- 
cellular calcium suggest that calmodulin-dependent activation 
in aortic smooth muscle is not restricted to agents which 
activate the  antiport via membrane receptor systems. 
The role of cytoplasmic Ca2' in activating the Na+/H+ 
antiport is controversial. In human fibroblasts (10-12) and 
the Alo smooth muscle cell line (9), elevation of the cyto- 
plasmic free Ca2+ concentration with the ionophore A23187 
markedly stimulated  Na+/H+  antiport activity. However, in 
other cell lines, calcium appears to play little role in  antiport 
activation (13,14). Since, as in the human fibroblasts and  the 
Alo cell line calmodulin appeared to be  involved in  activating 
the  Na+/H+  antiport of vascular smooth muscle, the role of 
calcium was investigated. Increasing intracellular Ca2+ by 
exposing the cells to  the calcium ionophore ionomycin induced 
a  rapid  but  transient alkalinization which could be inhibited 
by EIPA. Consistent with this finding of Ca2+-dependent 
activation of the  antiport, EIPA-sensitive "Na+ uptake was 
also increased during the alkalinization phase. This effect of 
ionomycin on antiport activity was also dependent on cal- 
modulin, making it unlikely that  it is due to cell shrinkage, 
as  has been suggested for thymic lymphocytes (31). Taken 
together these effects of ionomycin are  consistent with Caz+/ 
calmodulin processes being involved in the activation of the 
Na+/H+  antiport of vascular smooth muscle. 
Previous studies, including those on vascular smooth mus- 
cle (3, 4, 24), indicate that  the  Na+/H+  antiport is allosteri- 
cally activated by intracellular protons. Such activation en- 
ables the  antiport  to function in  pHi homeostasis because, 
whenever  pHi decreases, the  antiport becomes  more active to 
restore pHi. Our finding that  the ability of the  antiport  to 
restore pHi  following an acid load is  attenuated by preincu- 
bating vascular smooth muscle with concentrations of W-7 or 
trifluoroperazine, which inhibit Ca2+/calmodulin-dependent 
phosphorylation of myosin light chain in carotid smooth 
muscle (32), suggests that calmodulin processes also influence 
the degree to which allosteric mechanisms affect antiport 
activity. 
Activation of the antiport in aortic smooth muscle by 
intracellular acidosis is also dependent upon the presence of 
adequate cellular levels of ATP. When cellular ATP is de- 
pleted by preincubation with 2-deoxy-D-glucose (26), aortic 
smooth muscle cells were unable to recover from the  15 mM 
NH&1 induced acid load. This effect of ATP depletion by 2- 
deoxy-D-glucose  on antiport activation is not  a consequence 
of any reduction in  the transmembrane sodium gradient due 
to a fall in sodium extrusion by the Na+/K+-pump. Activation 
of the Na+/H' antiport of aortic smooth muscle by intracel- 
lular acidosis has been shown to be unaffected by inhibition 
of the Na+/K+-pump for periods up to 1 h (4). The finding 
that pHi of the cells fell by -0.4 pH units after 30 min 
incubation with 2-deoxy-D-glucose is also consistent with 
basal Na+/H+  antiport activity contributing to  the mainte- 
nance of normal pHi  in  these cells (4, 7). Our observations 
that ATP depletion of aortic smooth muscle attenuates  Na+/ 
H+  antiport activity by shifting  its dependence on the  intra- 
cellular proton concentration to more acidic pH levels are 
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consistent with recent observations in cultured human A431 
cells (26). However, in  addition to  the change in pHi depend- 
ence, ATP depletion in aortic  smooth muscle also reduces the 
maximal activity of the antiport.  This effect of ATP depletion 
on the maximal activity of the  Na+/H+  antiport is unlikely to 
be due to any alteration in the number of antiport units 
present in the cell membrane since a  rapid  insertion of anti- 
port  units from internal membrane sources does not  appear 
to be an important mechanism by which antiport activity is 
increased (32). Furthermore,  activation of the  Na+/H+  anti- 
port by intracellular acidosis, at least in isolated membrane 
vesicles, is not directly dependent upon the presence of ATP 
(1). Taken together, the effects of ATP depletion on both the 
pHi dependence and maximal activity of the Na+/H+  antiport 
suggests the presence of at least two ATP-dependent regula- 
tory sites for the antiport. The most likely mechanism by 
which ATP would  be  involved in  this regulation would  be  via 
multiple sites of protein phosphorylation. Certainly phos- 
phorylation has been proposed as  a mechanism by which Na+/ 
H+  antiport activity could  be regulated under some circum- 
stances (2, 25, 26, 29). Moreover, phosphorylation appears  to 
be an important mechanism by which a number of transmem- 
brane ion transport systems are regulated. Recently it has 
been shown that  the dihydropyridine-sensitive class of volt- 
age-activated calcium channel must be phosphorylated in 
order to open when the membrane is depolarized (33). Mul- 
tiple phosphorylation processes have also been shown to 
regulate the activity of the Ca2+-pump ATPase  in the sarco- 
plasmic reticulum of muscle (34, 35). Our observation sug- 
gesting that the Na+/H+ antiport is regulated by multiple 
phosphorylation mechanisms is consistent with recent obser- 
vations  in myoblasts where activation of the  antiport by serum 
was associated with a  shift of its pHi dependence toward more 
alkaline pH[ values and  an increase in its maximal activity at 
acidic pH (36). 
Much evidence has now accumulated which implicates the 
Na+/H+  antiport in regulating cell volume, intracellular  pH, 
and cell proliferation (1, 2). In aortic smooth muscle this 
antiport is the predominant mechanism by which the cells 
regulate pH; (4, 5, 15) and is also responsible for a large 
component of the sodium which enters via electroneural proc- 
esses (3, 5). Alterations in activity of the  Na+/H+  antiport 
could,  by its effects on sodium influx and  proton efflux, both 
increase and reduce vascular smooth muscle tone. Activation 
of the  antiport, by increasing the rate of proton efflux from 
cells, would elevate pH;, thereby increasing the affinity of 
Ca2+ for myofibrils (37). Similarly, any reduction in antiport 
activity is ensued by a lowering of pHi (4, 32, 38), thereby 
lowering the affinity of Ca2+ for myofibrils and vascular 
smooth muscle tone. Both increases and decreases in constric- 
tor tone have been reported when rat aortic strips, under 
conditions which induce intracellular alkalosis and acidosis, 
are exposed to  the agonist, noradrenaline (39). 
Our observations indicating that  the affinity of the Na+/ 
H+  antiport for intracellular  protons  as well as  its maximum 
activity in  cultured  aortic smooth muscle are dependent on 
calmodulin, Ca2+,  and ATP are  consistent with the involve- 
ment of calmodulin-dependent protein kinase systems in  its 
regulation. This,  taken,  together with the recent finding that 
protein kinase C-dependent processes also activate  this anti- 
port (51, indicates that  antiport activity in vascular smooth 
muscle  may  be subject to regulation via a number of kinase 
systems, as has been reported for lymphocytes (2, 25, 29). 
Precisely how these kinases might be involved in regulating 
activity clearly requires further investigation. However, the 
recent finding that platelet-derived growth factor, a  potent 
constrictor of coronary smooth muscle (40), also activates the 
Na+/H+  antiport  in cultured aortic smooth muscle  by calmod- 
ulin-dependent processes ( 6 )  supports previous suggestions 
that the Na+/H+ antiport facilitates or contributes to the 
maintenance of contracture (4,  5). Whether calmodulin-de- 
pendent activation represents  a general mechanism by  which 
the antiport is activated when vascular smooth muscle is 
exposed to different constrictor  agents requires further inves- 
tigation. 
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